Figures & data
Table I. Demographics and comorbidity for men diagnosed with prostate cancer and registered in the National Prostate Cancer Register (NPCR) of Sweden, the Cancer Register only (CR Only), and the Cause of Death Register only (DC Only).
Table II. Treatment for men diagnosed with prostate cancer in 2006–2009 and registered in the National Prostate Cancer Register, the Cancer Register only (CR Only), and the Cause of Death Register only (DC only).
Table III. Duration of perioperative hospital stay for radical prostatectomy for 19 683 men in the National Prostate Cancer Register, and 262 for men in the Cancer Register only (CR Only) registered 1998–2009.
Figure 1. (a) Prostate cancer mortality and mortality from other causes for men diagnosed with prostate cancer and registered in the National Prostate Cancer Register. (b) Prostate cancer and all-cause mortality for men diagnosed with prostate cancer and registered in the Cancer Register only. (c) Prostate cancer mortality for 698 men diagnosed with prostate cancer and registered in the Cause of Death Register only. *Date of start of androgen deprivation therapy: GnRH analogs, anti-androgens, or orchiectomy.
![Figure 1. (a) Prostate cancer mortality and mortality from other causes for men diagnosed with prostate cancer and registered in the National Prostate Cancer Register. (b) Prostate cancer and all-cause mortality for men diagnosed with prostate cancer and registered in the Cancer Register only. (c) Prostate cancer mortality for 698 men diagnosed with prostate cancer and registered in the Cause of Death Register only. *Date of start of androgen deprivation therapy: GnRH analogs, anti-androgens, or orchiectomy.](/cms/asset/4ddc8578-4200-4b2b-ac03-7122afe91667/ionc_a_939299_f0001_b.gif)